Dxterity Diagnostics Incorporated
Div Dxterity Diagnostics
CAGE Code: 4HQM5
NCAGE Code: 4HQM5
Status: Active
Type: Manufacturer
Dun & Bradstreet (DUNS): 784360385
Summary
Dxterity Diagnostics Incorporated, Div Dxterity Diagnostics is an Active Manufacturer with the Cage Code 4HQM5 and is tracked by Dun & Bradstreet under DUNS Number 784360385..
Address
2441 W 205Th St
Ste C100
Torrance CA 90501-1463
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Asternetics And Associates Inc Ecology Control Industries /Eci/ Aeronca Inc Aerospace Div/Torrance Sigma Technology Inc Measurement Science Enterprise Shimadzu Medical Systems Technical Devices Company Casio Phonemate Inc Radiaphone Co Inc Intelligence Intl Ltd Menemsha Development Group, Inc. Cove Capital Investments, Llc Celsat America Inc Martec Marketing Inc Sumitomo Electric U S A Inc International Protective Services Ring-O-Steel Inc Dba Signet Marine Elo Technologies Inc Tanaco Inc Jefferson Electronics Inc
Frequently Asked Questions (FAQ) for CAGE 4HQM5
- What is CAGE Code 4HQM5?
- 4HQM5 is the unique identifier used by NATO Organizations to reference the physical entity known as Dxterity Diagnostics Incorporated Div Dxterity Diagnostics located at 2441 W 205Th St, Ste C100, Torrance CA 90501-1463, United States.
- Who is CAGE Code 4HQM5?
- 4HQM5 refers to Dxterity Diagnostics Incorporated Div Dxterity Diagnostics located at 2441 W 205Th St, Ste C100, Torrance CA 90501-1463, United States.
- Where is CAGE Code 4HQM5 Located?
- CAGE Code 4HQM5 is located in Torrance, CA, USA.
Contracting History for CAGE 4HQM5 Most Recent 25 Records
- HHSO100201600034C
- Biodosimetry High-Throughput Diagnostic Tests
- 30 Jun 2021
- Biodosimetry High-Throughput Diagnostic Tests
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $24,965,136.00
- Department Of Health And Human Services (Hhs)
- HHSO100201600034C
- Igf::Ot::Igf Biodosimetry High-Throughput Diagnostic Tests
- 19 Jun 2018
- Igf::Ot::Igf Biodosimetry High-Throughput Diagnostic Tests
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $22,465,186.00
- Department Of Health And Human Services (Hhs)
- HHSN261201600051C
- Sbir Phase Ii Topic 315: Blood Test To Predict Radiation Toxicity In Patients Treated With Radiation Therapy
- 19 Sep 2016
- Sbir Phase Ii Topic 315: Blood Test To Predict Radiation Toxicity In Patients Treated With Radiation Therapy
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,498,643.00
- Department Of Health And Human Services (Hhs)
- HHSO100201600034C
- Extend Clin 0001 Pop, Increase Clin 0001 Obligation Amount By $2.8 Million, Move Clin 0002 Thru 0004 To Optional Services, And Revise Attachment #1 - Statement Of Work.
- 21 Dec 2018
- Extend Clin 0001 Pop, Increase Clin 0001 Obligation Amount By $2.8 Million, Move Clin 0002 Thru 0004 To Optional Services, And Revise Attachment #1 - Statement Of Work.
- Office Of Acq&Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $22,465,186.00
- Department Of Health And Human Services (Hhs)
- HHSO100201600034C
- Biodosimetry High-Throughput Diagnostic Tests
- 1 May 2020
- Biodosimetry High-Throughput Diagnostic Tests
- Office Of Acq&Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $24,965,136.00
- Department Of Health And Human Services (Hhs)
- HHSO100201600034C
- Biodosimetry High-Throughput Diagnostic Tests
- 31 Mar 2021
- Biodosimetry High-Throughput Diagnostic Tests
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $24,965,136.00
- Department Of Health And Human Services (Hhs)
- HHSN261201600051C
- Mod P00005 - Sbir Phase Ii Topic 315: Blood Test To Predict Radiation Toxicity In Patients Treated With Radiation Therapy
- 19 Aug 2021
- Mod P00005 - Sbir Phase Ii Topic 315: Blood Test To Predict Radiation Toxicity In Patients Treated With Radiation Therapy
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,396,540.45
- Department Of Health And Human Services (Hhs)
- HHSN261201600051C
- Sbir Phase Ii Topic 315: Blood Test To Predict Radiation Toxicity In Patients Treated With Radiation Therapy
- 18 Mar 2020
- Sbir Phase Ii Topic 315: Blood Test To Predict Radiation Toxicity In Patients Treated With Radiation Therapy
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,498,643.00
- Department Of Health And Human Services (Hhs)
- HHSO100201600034C
- Biodosimetry High-Throughput Diagnostic Tests
- 25 Sep 2020
- Biodosimetry High-Throughput Diagnostic Tests
- Office Of Acq&Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $24,965,136.00
- Department Of Health And Human Services (Hhs)
- HHSN261201600051C
- Sbir Phase Ii Topic 315: Blood Test To Predict Radiation Toxicity In Patients Treated With Radiation Therapy
- 19 Sep 2016
- Sbir Phase Ii Topic 315: Blood Test To Predict Radiation Toxicity In Patients Treated With Radiation Therapy
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,498,643.00
- Department Of Health And Human Services (Hhs)
- HHSN261201600051C
- Igf::Ot::Igf Sbir Phase Ii Topic 315: Blood Test To Predict Radiation Toxicity In Patients Treated With Radiation Therapy
- 13 Sep 2018
- Igf::Ot::Igf Sbir Phase Ii Topic 315: Blood Test To Predict Radiation Toxicity In Patients Treated With Radiation Therapy
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,498,643.00
- Department Of Health And Human Services (Hhs)